Here, we generated progressive FSHD-like pathology in ACTA1-MCM/FLExDUX4 mice and then treated the animals with vivoPMO-PACS4, an antisense compound that efficiently downregulates DUX4. The gene discussed is DUX4; the disease is facioscapulohumeral muscular dystrophy.